-- Yielding verified highly-secreting single-cell clones in less than 24
hours (vs. weeks)
-- Isolating ten-fold more highly secreting clones than traditional
-- Selecting optimal clones based on real-time assessment of secretion,
growth and stability
-- Reducing time to confirmed highly-secreting clones by more than 50%
-- Delivering up to 90% reduction in labor and material costs
-- Enabling processing of multiple projects / cell lines in parallel
"The increasing pressures on bioprocess development teams to improve manufacturing productivity and shorten timelines have not been adequately addressed," said Fred Koller, Ph.D., Cyntellect's President and Chief Executive Officer. "Our goal with CellXpress is to provide a reliable, scalable and efficient product that customers can purchase and use in-house to empower significant productivity gains, while also helping get new potential drugs to market sooner."
Previously, CellXpress was available only as a fee for service from SAFC Biosciences. Now, customers can purchase the technology as a product directly from Cyntellect and its distributors allowing bioprocessing teams to harvest the productivity benefits of CellXpress as part of their in-house programs.
Cyntellect, Inc. is a life sciences company committed to
revolutionizing the use of living cells in life science research and
cellular therapy. The Company combines expertise in high-speed cell imaging
and laser-based manipulation to develop products that enable novel cell
imaging, purification, and transfection capabilities to enhance the
Copyright©2008 PR Newswire.
All rights reserved